Project Grant HT94252510893
Award Date
8/1/25
Completion Date
7/31/26
Dollars Obligated
$154K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,560,000.00 to the University of Texas Health Science Center at Houston (UTHealth) to develop drug conjugates of modified LGR4/5/6 ligands for cancer treatment. The funding supports UTHealth's advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award period runs from August 1, 2024...
This Project Grant award, valued at $152,135, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by the University of Texas Health Science Center at Houston (UTHealth) to unravel the role of the RB1 gene in regulating enhancer control and chromatin architecture governing gene transcription in osteosarcoma. The research aims to advance the scientific understanding of osteosarcoma,...
The federal Project Grant award, with ID HT94252410992, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, totaling $2,710,479.00, will fund a research initiative led by the University of Texas M.D. Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The award's performance period is from August 15, 2024 to...
The University of Texas Health Science Center at San Antonio received a $1,565,298 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) on September 1, 2025. The grant will support research to target the METTL3 protein and overcome drug resistance in metastatic clear cell renal cell carcinoma. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative, advanced...
This $1,559,880 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support the "PEGASUS: PREGNANCY COMPLICATIONS IN AYA CANCER SURVIVORS" research project at the University of Texas Health Science Center at Houston (UTHealth). The award, effective April 1, 2025 through March 31, 2029, will fund advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
The federal Project Grant award of $1,496,576.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research at Baylor College of Medicine in Houston, Texas, aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational domains, will focus on innovative investigations across multiple medical...
This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative scientific...
This federal Project Grant award of $443,632.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The University of Texas M.D. Anderson Cancer Center to investigate the tissue-specific effects of VHL germline variants in von Hippel-Lindau syndrome. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing critical biomedical research in cancer-related genetic...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $1,559,997 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports a pharmacology and efficacy study of a novel, blood-brain barrier (BBB)-permeable agent for the treatment of breast cancer brain metastases. The project will be conducted over a 3-year period from September 1, 2024 to August 31, 2027. The Military...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...